601607 上海醫藥
按盤價 
16.390 +0.140 (+0.862%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.544 | 7.759 | 6.494 | 5.558 | 9.650 |
| 總資產報酬率 ROA (%) | 1.479 | 2.520 | 2.102 | 1.838 | 3.107 |
| 投入資產回報率 ROIC (%) | 2.481 | 4.194 | 3.548 | 3.146 | 5.510 | 邊際利潤分析 |
| 銷售毛利率 (%) | 11.026 | 10.726 | 11.129 | 12.036 | 13.142 |
| 營業利潤率 (%) | 3.824 | 3.506 | 2.958 | 2.946 | 3.886 |
| 息稅前利潤/營業總收入 (%) | 4.290 | 3.959 | 3.452 | 3.281 | 4.363 |
| 淨利潤/營業總收入 (%) | 2.944 | 2.459 | 2.133 | 1.985 | 3.014 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 86.181 | 74.300 | 94.447 | 103.288 | 80.311 |
| 價值變動淨收益/利潤總額(%) | 14.725 | 35.665 | 7.285 | 4.772 | 8.536 |
| 營業外收支淨額/利潤總額(%) | -0.149 | -1.245 | -1.505 | -8.689 | -2.342 | 償債能力分析 |
| 流動比率 (X) | 1.342 | 1.335 | 1.363 | 1.327 | 1.351 |
| 速動比率 (X) | 1.038 | 0.999 | 1.054 | 1.028 | 1.039 |
| 資產負債率 (%) | 61.463 | 61.489 | 62.143 | 62.105 | 60.632 |
| 帶息債務/全部投入資本 (%) | 41.707 | 43.274 | 43.467 | 42.103 | 39.011 |
| 股東權益/帶息債務 (%) | 132.520 | 124.633 | 124.672 | 130.853 | 149.257 |
| 股東權益/負債合計 (%) | 52.944 | 52.937 | 52.140 | 52.052 | 55.824 |
| 利息保障倍數 (X) | 9.108 | 7.978 | 6.416 | 5.748 | 7.708 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 105.626 | 102.470 | 99.441 | 96.601 | 96.888 |
| 存貨周轉天數 (天) | 60.392 | 59.940 | 55.605 | 55.882 | 54.997 |
| 備註： | 即時報價更新時間為 01/09/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
